Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Pais

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
American Heart Journal|June 25, 2004
Tackling the challenge of cardiovascular disease burden in developing countriesSalim Yusuf, Mario Vaz, Prem Pais
The New England Journal of Medicine|April 29, 2021
Polypill in Persons without Cardiovascular Disease. ReplySalim Yusuf, Philip Joseph, Prem Pais
Heart (British Cardiac Society)|October 16, 2007
Perspectives on the management of coronary artery disease in IndiaGanesan Karthikeyan, Denis Xavier, Doriaraj Prabhakaran, et al.
The Indian Journal of Medical Research|October 14, 2015
High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspectiveDeepak Y Kamath, Denis Xavier, Alben Sigamani, et al.
Indian Heart Journal|April 11, 2009
Polypharmacotherapy for primary prevention of cardiovascular diseaseDenis Xavier, P J Devereaux, Abhinav Goyal, et al.
International Journal of Cardiology|June 28, 2005
Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factorsRajeev Gupta, Anoop Misra, Prem Pais, et al.
Nature Clinical Practice. Cardiovascular Medicine|December 24, 2008
The need to test the theories behind the Polypill: rationale behind the Indian Polycap StudyDenis Xavier, Prem Pais, Alben Sigamani, et al.
Circulation|November 25, 2010
The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directionsEva Lonn, Jackie Bosch, Koon K Teo, et al.
Circulation. Cardiovascular Quality and Outcomes|July 13, 2012
Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigatorsSalim Yusuf, Prem Pais, Alben Sigamani, et al.
Heart (British Cardiac Society)|May 31, 2023
Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysisGilles R Dagenais, Prem Pais, Peggy Gao, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
American Heart Journal|June 25, 2004
Tackling the challenge of cardiovascular disease burden in developing countriesSalim Yusuf, Mario Vaz, Prem Pais
The New England Journal of Medicine|April 29, 2021
Polypill in Persons without Cardiovascular Disease. ReplySalim Yusuf, Philip Joseph, Prem Pais
Heart (British Cardiac Society)|October 16, 2007
Perspectives on the management of coronary artery disease in IndiaGanesan Karthikeyan, Denis Xavier, Doriaraj Prabhakaran, et al.
The Indian Journal of Medical Research|October 14, 2015
High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspectiveDeepak Y Kamath, Denis Xavier, Alben Sigamani, et al.
Indian Heart Journal|April 11, 2009
Polypharmacotherapy for primary prevention of cardiovascular diseaseDenis Xavier, P J Devereaux, Abhinav Goyal, et al.
International Journal of Cardiology|June 28, 2005
Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factorsRajeev Gupta, Anoop Misra, Prem Pais, et al.
Nature Clinical Practice. Cardiovascular Medicine|December 24, 2008
The need to test the theories behind the Polypill: rationale behind the Indian Polycap StudyDenis Xavier, Prem Pais, Alben Sigamani, et al.
Circulation|November 25, 2010
The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directionsEva Lonn, Jackie Bosch, Koon K Teo, et al.
Circulation. Cardiovascular Quality and Outcomes|July 13, 2012
Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigatorsSalim Yusuf, Prem Pais, Alben Sigamani, et al.
Heart (British Cardiac Society)|May 31, 2023
Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysisGilles R Dagenais, Prem Pais, Peggy Gao, et al.
Pageof 11